Evaluation of Sodium Pentaborate Topical Ointment on Hemorrhoid Symptoms

Early Phase 1

Recruiting

Conditions: Hemorrhoid.
Hemorrhoids and perianal venous thrombosis

Registration Number: IRCT20190701044062N1

Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 53

Inclusion Criteria

65-18 years old
Patients with hemorrhoids and those with I, II, III or IV internal hemorrhoid disorder without need for emergency interventions based on physical examination
The presence of anal bleeding as one of the symptoms of a hemorrhoid in the patient (according to the Sodergren scoring system)
Non-use of a drug other than the drug and control drug for the treatment of hemorrhoids during the study period

Exclusion Criteria

Disorders and analgesics including inflammatory bowel disease, Fisher, fistula and perianal rash, rectal prolapse, rectus, benign or malignant tumor of the anus and rectum, and perianal infections
Patients with sodium phentetrazur susceptibility or a history of skin sensitivity to vaseline
Pregnancy or breastfeeding
Patients with severe heart disease, neurology, liver and kidney disease and blood diseases
Taking any local analgesic for the past 7 days
Prohibition of topical use of vaseline or sodium panteurate
The history of permanent prolapse is the entire thickness of the rectum

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severe itching. Timepoint: 25 to 30 days. Method of measurement: questionnaire and Sodergren Scoring System.;Severity of pain during rest. Timepoint: 25 to 30 days. Method of measurement: Severity of pain during rest.;Pain intensity when starting fecal excretion. Timepoint: 25 to 30 days. Method of measurement: Pain intensity when starting fecal excretion.;Frequent feeling of mass in the anus. Timepoint: 25 to 30 days. Method of measurement: Frequent feeling of mass in the anus.;The severity of the outgrowth of the hemorrhoid mass. Timepoint: 25 to 30 days. Method of measurement: Clinical evaluation.;The degree of anoscopic hemorrhoids. Timepoint: 25 to 30 days. Method of measurement: Clinical evaluation.;Number of hemorrhoid hemorrhages. Timepoint: 25 to 30 days. Method of measurement: Clinical evaluation.

Secondary Outcome Measures